These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23332706)

  • 21. G protein-coupled receptors: a count of 1001 conformations.
    Vauquelin G; Van Liefde I
    Fundam Clin Pharmacol; 2005 Feb; 19(1):45-56. PubMed ID: 15660959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDZ-domain arrays for identifying components of GPCR signaling complexes.
    Day P; Kobilka B
    Trends Pharmacol Sci; 2006 Oct; 27(10):509-11. PubMed ID: 16904197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photocrosslinking/label transfer: A key step in mapping short alpha-neurotoxin binding site on nicotinic acetylcholine receptor.
    Kessler P; Thai R; Beau F; Tarride JL; Ménez A
    Bioconjug Chem; 2006; 17(6):1482-91. PubMed ID: 17105227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-linking strategies to study peptide ligand-receptor interactions.
    Becker JM; Naider F
    Methods Enzymol; 2015; 556():527-47. PubMed ID: 25857798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
    Fuxe K; Marcellino D; Borroto-Escuela DO; Frankowska M; Ferraro L; Guidolin D; Ciruela F; Agnati LF
    J Recept Signal Transduct Res; 2010 Oct; 30(5):272-83. PubMed ID: 20684666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.
    Breitwieser GE
    Circ Res; 2004 Jan; 94(1):17-27. PubMed ID: 14715532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands.
    Goetzl EJ
    FASEB J; 2007 Mar; 21(3):638-42. PubMed ID: 17194692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights from structural biology into the druggability of G protein-coupled receptors.
    Mason JS; Bortolato A; Congreve M; Marshall FH
    Trends Pharmacol Sci; 2012 May; 33(5):249-60. PubMed ID: 22465153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation.
    Peeters MC; van Westen GJ; Li Q; IJzerman AP
    Trends Pharmacol Sci; 2011 Jan; 32(1):35-42. PubMed ID: 21075459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
    Leach K; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2007 Aug; 28(8):382-9. PubMed ID: 17629965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [G-protein-coupled receptors dimers and oligomers: for which purpose? The GABA(B) receptor under investigation].
    Kniazeff J; Pin JP
    Med Sci (Paris); 2012 Oct; 28(10):858-63. PubMed ID: 23067417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both ligand- and cell-specific parameters control ligand agonism in a kinetic model of g protein-coupled receptor signaling.
    Kinzer-Ursem TL; Linderman JJ
    PLoS Comput Biol; 2007 Jan; 3(1):e6. PubMed ID: 17222056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical model for ligand/receptor/G-protein dynamics and actin polymerization in human neutrophils.
    Adams JA; Omann GM; Linderman JJ
    J Theor Biol; 1998 Aug; 193(4):543-60. PubMed ID: 9745752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical biology methods for investigating G protein-coupled receptor signaling.
    Huber T; Sakmar TP
    Chem Biol; 2014 Sep; 21(9):1224-37. PubMed ID: 25237865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor.
    Buck E; Wells JA
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2719-24. PubMed ID: 15710877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.